Study Comparing a Pantoprazole Formulation to the Currently Marketed Tablet for GERD and Erosive Esophagitis
Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate pharmacodynamic comparability between the
pantoprazole spheroid formulation and the marketed tablet formulation.